Delivery Order SPE2DB22D2211-SPE2DB25FSCMS
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,749.25 to supply Dexcom G7 sensors, with an ultimate completion date of July 29, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a $3,093.60 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed price contract. This non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,905.95 to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract. This non-set-aside award, issued on August 7, 2025, with completion targeted for August 8, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The sensors will be delivered to the contractor's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $3,361.44 to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors, valued at $1,180.24. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,278.84 delivery order contract to AmerisourceBergen Drug Corp for Dexcom G7 continuous glucose monitoring sensors. The contract, which is non-set-aside and competitively awarded, carries a firm fixed price structure with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,250.55 for Dexcom G7 sensors, with an ultimate completion date of September 15, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,546.80 to AmerisourceBergen Drug Corp for the supply of Dexcom G7 sensors. This contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of August 12, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a $2,599.82 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with an ultimate completion date of June 2, 2025. This is a non-set-aside competitive award issued as a child contract, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, delivers medical supplies and...
- The Defense Logistics Agency awarded a delivery order valued at $1,493.49 to AmerisourceBergen Drug Corp for Dexcom G7 sensors, with a completion date of July 21, 2025. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitively awarded transaction with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCMSDelivery Order
The Defense Logistics Agency awarded a $19,957.69 delivery order to AmerisourceBergen Drug Corp for Dexcom G7 sensors under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by August 11, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company maintains a significant IDC with DLA valued at $999,999,999.00 through December 2026, which functions as a comprehensive global pharmaceutical support vehicle enabling supply of medications, medical devices, and healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. The Dexcom G7 sensors—continuous glucose monitoring devices used in diabetes management—represent the type of specialized medical supplies the company routinely delivers through its federal contract portfolio and DLA relationship.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.0k | 8/8/25 |